Skip to main content
. 2015 Jan 31;9(6):1081–1090. doi: 10.1016/j.molonc.2015.01.003

Table 2.

PAM50, Claudin‐low and ROR of FTs breast tumors.

Group FAD Juvenile FAD Benign PT Borderline PT Malignant PT
N % N % N % N % N %
PAM50 Basal‐like 0 0% 1 20% 0 0% 0 0% 10 91%
Luminal A 1 4% 0 0% 1 5% 0 0% 0 0%
Normal 25 96% 4 80% 18 95% 5 100% 1 9%
Total 26 5 19 5 11
PAM50 + Claudin‐low Basal‐like 0 0% 1 20% 0 0% 0 0% 3 27%
Claudin‐low 0 0% 0 0% 0 0% 0 0% 7 64%
Luminal A 1 4% 0 0% 1 5% 0 0% 0 0%
Normal 25 96% 4 80% 18 95% 5 100% 1 9%
Total 26 5 19 5 11
PAM50‐ROR High 0 0% 0 0% 0 0% 0 0% 8 73%
Med 2 8% 2 40% 1 5% 2 40% 3 27%
Low 24 92% 3 60% 18 95% 3 60% 0 0%
Total 26 5 19 5 11